Stevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin

Stevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare mucocutaneous, unpredictable, life-threatening drug side reactions. A very rare case of norfloxacin-induced SJS/TEN overlap with uncommon clinical presentation in a patient with a suspected urinary tract infection is report...

Full description

Bibliographic Details
Main Authors: Maciejewska, Jolanta, Jankowski, Marek, Zegarska, Barbara, Czajkowski, Rafał
Format: Online
Language:English
Published: Termedia Publishing House 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112256/
id pubmed-4112256
recordtype oai_dc
spelling pubmed-41122562014-08-05 Stevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin Maciejewska, Jolanta Jankowski, Marek Zegarska, Barbara Czajkowski, Rafał Case Report Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare mucocutaneous, unpredictable, life-threatening drug side reactions. A very rare case of norfloxacin-induced SJS/TEN overlap with uncommon clinical presentation in a patient with a suspected urinary tract infection is reported. The SJS/TEN management with possible treatment capabilities are discussed. In spite of only two previous reports of norfloxacin-induced SJS and TEN we believe that awareness of norfloxacin adverse reactions needs to be raised among prescribers. Termedia Publishing House 2014-06-13 2014-06 /pmc/articles/PMC4112256/ /pubmed/25097494 http://dx.doi.org/10.5114/pdia.2014.40796 Text en Copyright © 2014 Termedia http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Maciejewska, Jolanta
Jankowski, Marek
Zegarska, Barbara
Czajkowski, Rafał
spellingShingle Maciejewska, Jolanta
Jankowski, Marek
Zegarska, Barbara
Czajkowski, Rafał
Stevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin
author_facet Maciejewska, Jolanta
Jankowski, Marek
Zegarska, Barbara
Czajkowski, Rafał
author_sort Maciejewska, Jolanta
title Stevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin
title_short Stevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin
title_full Stevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin
title_fullStr Stevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin
title_full_unstemmed Stevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin
title_sort stevens-johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin
description Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare mucocutaneous, unpredictable, life-threatening drug side reactions. A very rare case of norfloxacin-induced SJS/TEN overlap with uncommon clinical presentation in a patient with a suspected urinary tract infection is reported. The SJS/TEN management with possible treatment capabilities are discussed. In spite of only two previous reports of norfloxacin-induced SJS and TEN we believe that awareness of norfloxacin adverse reactions needs to be raised among prescribers.
publisher Termedia Publishing House
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112256/
_version_ 1613118230160736256

Similar Items